Clinical trial
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
NCT00007189 · Seattle Institute for Biomedical and Clinical Research, Other · Completed
Key facts
| NCT number | NCT00007189 |
|---|---|
| Title | Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) |
| Official title | Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) |
| Lead sponsor | Seattle Institute for Biomedical and Clinical Research, Other |
| Collaborators | National Institute on Aging (NIA) NIH VA Puget Sound Health Care System U.S. Fed University of Washington Johns Hopkins University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Naproxen Sodium (Aleve), Celecoxib (Celebrex) |
| Enrollment | 2,625 |
| Start date | Jan 1, 2001 |
| Primary completion | May 1, 2007 |
| First posted | Dec 14, 2000 |
| Last update posted | Oct 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: